Aware of the high-tech workforce shortage amid tech giants flocking to Vietnam, the government has proposed training roadmaps alongside direct initiatives by tech corporations, with a strong focus on ...
Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six ...
With new legislation and noteworthy policies on sci-tech and innovation expected this year, businesses are hoping the right ...
It was an extremely busy week in the biotech sector, with several companies making important presentations at the J.P. Morgan ...
Bank of America Securities analyst Alec Stranahan maintained a Hold rating on Vir Biotechnology (VIR – Research Report) yesterday and set a ...
Vir Biotechnology (NASDAQ:VIR – Get Free Report) had its price objective raised by Leerink Partners from $18.00 to $20.00 in ...
Leerink Partners analyst Roanna Ruiz reiterated a Buy rating on Vir Biotechnology (VIR – Research Report) on January 13 and set a price target ...